A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer
Titel:
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer
Auteur:
Do, Khanh Cao, Liang Kang, Zhigang Turkbey, Baris Lindenberg, Maria L. Larkins, Erin Holkova, Beata Steinberg, Seth M. Raffeld, Mark Peer, Cody J. Figg, William D. Eugeni, Michelle Jacobs, Paula Choyke, Peter Wright, John J. Doroshow, James H. Kummar, Shivaani